These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8640810)

  • 1. Induction of muscle protein degradation and weight loss by a tumor product.
    Todorov PT; McDevitt TM; Cariuk P; Coles B; Deacon M; Tisdale MJ
    Cancer Res; 1996 Mar; 56(6):1256-61. PubMed ID: 8640810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.
    McDevitt TM; Todorov PT; Beck SA; Khan SH; Tisdale MJ
    Cancer Res; 1995 Apr; 55(7):1458-63. PubMed ID: 7882353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolic factors in cancer cachexia.
    Tisdale MJ; McDevitt TM; Todorov PT; Cariuk P
    In Vivo; 1996; 10(2):131-6. PubMed ID: 8744791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cancer cachectic factor.
    Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
    Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of animal models for head and neck cancer cachexia.
    Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
    Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a tumor lipid-mobilizing factor.
    Todorov PT; McDevitt TM; Meyer DJ; Ueyama H; Ohkubo I; Tisdale MJ
    Cancer Res; 1998 Jun; 58(11):2353-8. PubMed ID: 9622074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia.
    Bhogal AS; Lorite ML; Tisdale MJ
    Anticancer Res; 2006; 26(6B):4149-54. PubMed ID: 17201126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of muscle protein degradation by a tumour factor.
    Lorite MJ; Cariuk P; Tisdale MJ
    Br J Cancer; 1997; 76(8):1035-40. PubMed ID: 9376263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF).
    Islam-Ali B; Khan S; Price SA; Tisdale MJ
    Br J Cancer; 2001 Sep; 85(5):758-63. PubMed ID: 11531264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
    Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
    Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
    Chand A; Wyke SM; Tisdale MJ
    Cancer Lett; 2005 Feb; 218(2):215-22. PubMed ID: 15670899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia.
    Russell ST; Tisdale MJ
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):409-14. PubMed ID: 15899583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.
    Johnson VG; Schlom J; Paterson AJ; Bennett J; Magnani JL; Colcher D
    Cancer Res; 1986 Feb; 46(2):850-7. PubMed ID: 3940648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.
    Belizário JE; Lorite MJ; Tisdale MJ
    Br J Cancer; 2001 Apr; 84(8):1135-40. PubMed ID: 11308266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen.
    Barton BE; Murphy TF
    Cytokine; 2001 Dec; 16(6):251-7. PubMed ID: 11884029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate.
    Russell ST; Siren PM; Siren MJ; Tisdale MJ
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):517-27. PubMed ID: 19112551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.
    Tamura S; Ouchi KF; Mori K; Endo M; Matsumoto T; Eda H; Tanaka Y; Ishitsuka H; Tokita H; Yamaguchi K
    Clin Cancer Res; 1995 Nov; 1(11):1353-8. PubMed ID: 9815931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development and characterization of monoclonal Antibody against M-like protein of Streptococcus equi subsp. zooepidemicus from pig].
    Fan HJ; He S; Lu CP
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):710-3. PubMed ID: 17944378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-host interactions.
    Tisdale MJ
    J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
    Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.